CMS seeks input on strengthening domestic supply chains for PPE, essential medicines 

Jan 27, 2026 - 03:18 PM
HRSA-340B-aha-comment

The Centers for Medicare & Medicaid Services Jan. 26 released an advanced notice of proposed rulemaking seeking comments on potential future policies to promote hospital procurement of domestically produced personal protective equipment and essential medicines. CMS is exploring the potential establishment of a “Secure American Medical Supplies” designation for hospitals that procure a minimum percentage of American-made PPE and essential medicines. CMS also seeks input on a potential separate Medicare payment to hospitals that achieve the designation, and a structural measure for the hospital inpatient quality reporting program asking hospitals to attest to procuring minimum percentages of domestically-made PPE and essential medicines. CMS is accepting comments through March 30. 

Related News Articles

Headline
Olympus expands recall of endoscope needles
Olympus has expanded a voluntary recall of its ViziShot 2 FLEX Needles due to complaints of device components ejecting or attaching during…
Headline
U.S. reaches trade agreement with U.K. on drug pricing
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…
Headline
AHA expresses concerns on potential tariffs for PPE, other medical goods
The AHA urged the Department of Commerce Oct. 17 to take a balanced approach to ensuring dependable and affordable access to personal protective equipment,…
Headline
Resource hub features tools, information on tariffs impacting health care supply chain
The AHA’s Association for Health Care Resource & Materials Management has created a webpage featuring resources on tariffs impacting the health care supply…
Headline
AHA calls for Senate committee to strengthen supply chain for pharmaceuticals, medical devices
The AHA provided a statement of record to the Senate Special Committee on Aging for a hearing Oct. 8 on the pharmaceutical and medical device supply chains.…
Headline
President announces new tariffs, including for certain pharmaceuticals, set to begin Oct. 1 
President Trump, late Sept. 25, announced that starting Oct. 1, the U.S. will impose a 100% tariff on any branded or patented pharmaceutical product, unless a…